CT Perfusion Technology Monitors Blood Flow to Predict Ovarian Cancer Treatment Response
Patients with advanced ovarian cancer have a very high relapse rate following primary treatment, with 60 to 85% of patients relapsing. Treatment planning is an important factor in patient care, but few reliable options exist to help physicians accu...
Source: Medgadget - Category: Medical Devices Authors: Iris Kulbatski Tags: Ob/Gyn Oncology Radiology Source Type: blogs
More News: Brain | Brain Cancers | Canada Health | Cancer | Cancer & Oncology | Clinical Trials | Legislation | Medical Devices | Neurology | Ovarian Cancer | Ovaries | Perfusion | PET Scan | Radiology | Stroke | Study